See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367083_2026_Sonoma_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001367083, Sonoma Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,648,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 225,000 |
| 3 | remainder_Assets | 820,000 |
| 4 | LiabilitiesCurrent | 4,096,000 |
| 5 | LiabilitiesNoncurrent | 27,000 |
| 6 | remainder_Liabilities | 5,159,000 |
| 7 | CostOfGoodsAndServicesSold | 8,741,335 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,290,498 |
| 9 | ResearchAndDevelopmentExpense | 1,818,242 |
| 10 | remainder_Expenses | 321,564 |
| 11 | remainder_Revenues | 14,508,424 |
| 12 | remainder_NetIncome | 429,542 |
| 13 | remainder_ComprehensiveNetIncome | -887,556 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,693,000 |
| 1 | Liabilities | 9,282,000 |
| 2 | Expenses | 18,171,639 |
| 3 | Revenues | 14,508,424 |
| 4 | StockholdersEquity | 4,411,000 |
| 5 | NetIncome | -3,233,673 |
| 6 | ComprehensiveNetIncome | -3,677,451 |
| 7 | BaseVar | 28,486,080 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.517 |
| 9 | EconomicCapitalRatio | 1.90 |